CRMD
CorMedix Inc.
Nasdaq Pharmaceutical Preparations Non-accelerated filer

Key Financials

Operating Income
$150.1M
↑ 771.6%
Revenue
$229.4M
N/A
Total Assets
$826.1M
↑ 595.1%
EPS (Diluted)
$2.04
↑ 780.0%
Net Income
$163.1M
↑ 1009.4%
Total Liabilities
$420.8M
↑ 1130.9%
Shareholders' Equity
$405.3M
↑ 378.8%
Cash & Equivalents
$144.8M
↑ 256.3%

Recent SEC Filings

Form Type Filed Date Link
4 9/18/2026 View on SEC
4 9/1/2026 View on SEC
4 9/1/2026 View on SEC
4 9/1/2026 View on SEC
10-Q 8/13/2026 View on SEC
8-K 8/13/2026 View on SEC
8-K 8/7/2026 View on SEC
8-K 7/2/2026 View on SEC
8-K 7/1/2026 View on SEC
S-8 POS 6/25/2026 View on SEC

Company Information

Field Value
Ticker CRMD
Company Name CorMedix Inc.
CIK 1410098
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 908-517-9500